![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication June 5, 2006.
Revised August 12, 2006.
Accepted for publication August 28, 2006.
The isolated mouse whole bladder was used to study in
vitro bladder overactivity evoked by intramural nerve
sensitization with bradykinin, mimicking neurogenic
bladder overactivity secondary to bladder inflammation.
Intravesical pressure responses to intramural electrical
stimulation (EFS) of intramural nerves were measured
under isovolumetric condition. Validation showed that
carbachol produced a dose response curve closely
mirroring that observed in the isolated muscle strips,
and demonstrated the dual nature of electrically evoked
neurotransmission, consisting of a cholinergic component
largely mediated by M3 receptors and a purinergic
component mediated by P2X receptors. ATP generated a
biphasic dose response curve, suggesting that the P2X
receptors may be heterogeneous in distribution.
Characterization of bradykinin receptors showed
bradykinin to be extremely potent in exciting the
bladder, producing a dose response curve with an EC50 of
90nM, and bradykinin also enhanced electrically evoked
bladder contractions. These effects were inhibited by the
B2 receptor antagonist HOE 140 but not the B1 receptor
antagonist desArge10HOE 140 and were also modulated by
,
,methyleneATP. The isolated mouse whole bladder has
proved a viable, robust model in which to demonstrate the
pharmacological characteristic of the bladder, and adds
to the repertoire of in vitro tools for investigating
potential therapeutic agents.
Key words:
Bradykinin, bladder overactivity, intravesical pressure, isovolumetric, mouse, purinoceptors
This article has been cited by other articles: